Literature DB >> 9099477

Carcinoma of the thyroid manifested as hyperthyroidism caused by functional bone metastasis.

K Ikejiri1, M Furuyama, T Muranaka, H Anai, S Takeo, K Sakai, M Saku, K Yoshida.   

Abstract

A rare case of hyperthyroidism in the presence of a functioning bone metastasis secondary to an occult thyroid cancer is reported. A 59-year-old woman's pelvic bone metastasis was much too extensive and hypervascular to permit resection. An I-131 scan showed striking activity in the pelvic metastasis, which reflected ectopic excessive production of thyroid hormone by a functioning metastatic thyroid carcinoma. After total thyroidectomy, the patient received I-131 ablation and transcutaneous intra-arterial embolization therapy but her metastasis progressively enlarged. Microscopically, concomitant follicular and papillary cancer was found in close proximity to the thyroid. The patient now has vertebral metastases, and her hyperthyroid state still requires methymazole to prevent thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099477     DOI: 10.1097/00003072-199704000-00003

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Metastatic Follicular Thyroid Carcinoma Secreting Thyroid Hormone and Radioiodine Avid without Stimulation: A Case Report and Literature Review.

Authors:  Syed A Abid; Brendan C Stack; Donald L Bodenner
Journal:  Case Rep Endocrinol       Date:  2014-10-07

2.  Hyperfunctioning papillary thyroid carcinoma: A case report with literature review.

Authors:  Abdulwahid M Salih; F H Kakamad; Han Nihad
Journal:  Int J Surg Case Rep       Date:  2016-08-03

3.  An upper cervical cord compression secondary to occult follicular thyroid carcinoma metastases successfully treated with multiple radioiodine therapies: A clinical case report.

Authors:  Ping Dong; Ni Chen; Lin Li; Rui Huang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.